首页> 美国卫生研究院文献>Human Genome Variation >Identification of a novel GLA mutation (F69 L) in a Japanese patient with late-onset Fabry disease
【2h】

Identification of a novel GLA mutation (F69 L) in a Japanese patient with late-onset Fabry disease

机译:在日本晚期法布里病患者中鉴定出新的GLA突变(F69 L)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fabry disease is an X-linked recessive inborn error of glycosphingolipid catabolism caused by a mutation in the GLA gene. We sequenced the α-galactosidase A gene (GLA) of a patient who had been clinically diagnosed with late-onset Fabry disease. Abundant globotriaosylceramide was present in his urine, which indicated typical Fabry disease. Here, we report a novel hemizygous mutation, c.207C>A (Phe69 Leu), which caused a mild/late-onset form of Fabry disease.
机译:法布里病是由GLA基因突变引起的糖鞘脂分解代谢的X连锁隐性先天性错误。我们对已被临床诊断为迟发性法布里病的患者的α-半乳糖苷酶A基因(GLA)进行了测序。他的尿液中存在大量的globotriaosylceramide,表明典型的法布里病。在这里,我们报告了一个新的半合子突变,c.207C> A(Phe69 Leu),引起轻度/晚发形式的法布里病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号